 NEW YORK, March 4, 2021 PRNewswire -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Five Prime Therapeutics, Inc. Five Prime or the Company NASDAQ: FPRX in connection with the proposed acquisition of... 